Results     03-Jun-19
Announcements
Gufic BioSciences standalone net profit rises 472.38% in the March 2019 quarter
Sales rise 16.02% to Rs 91.55 crore
Net profit of Gufic BioSciences rose 472.38% to Rs 6.01 crore in the quarter ended March 2019 as against Rs 1.05 crore during the previous quarter ended March 2018. Sales rose 16.02% to Rs 91.55 crore in the quarter ended March 2019 as against Rs 78.91 crore during the previous quarter ended March 2018.

For the full year,net profit rose 32.10% to Rs 21.77 crore in the year ended March 2019 as against Rs 16.48 crore during the previous year ended March 2018. Sales rose 14.75% to Rs 350.40 crore in the year ended March 2019 as against Rs 305.35 crore during the previous year ended March 2018.

ParticularsQuarter EndedYear Ended
 Mar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.
Sales91.5578.91 16 350.40305.35 15
OPM %13.6611.42 -13.0212.62 -
PBDT12.387.81 59 40.0032.76 22
PBT10.746.54 64 35.3528.36 25
NP6.011.05 472 21.7716.48 32

Previous News
  Gufic BioSciences standalone net profit rises 9.44% in the December 2023 quarter
 ( Results - Announcements 15-Feb-24   11:34 )
  Gufic BioSciences standalone net profit declines 2.04% in the June 2023 quarter
 ( Results - Announcements 12-Aug-23   07:35 )
  Gufic Biosciences hits record high on CDSCO nod for Isavuconazonium Sulfate API
 ( Hot Pursuit - 12-Apr-22   10:48 )
  Gufic BioSciences standalone net profit declines 6.52% in the December 2018 quarter
 ( Results - Announcements 16-Feb-19   16:02 )
  Gufic BioSciences to hold board meeting
 ( Corporate News - 17-Aug-20   12:05 )
  Gufic BioSciences to conduct AGM
 ( Corporate News - 05-Sep-23   15:21 )
  Gufic BioSciences schedules board meeting
 ( Corporate News - 04-Nov-17   10:56 )
  Gufic BioSciences to table results
 ( Corporate News - 08-Feb-18   11:37 )
  Gufic BioSciences standalone net profit rises 101.82% in the March 2016 quarter
 ( Results - Announcements 31-May-16   17:20 )
  Gufic Bio rises on TGA, ANVISA nod for Parecoxib injection
 ( Hot Pursuit - 12-Sep-23   11:25 )
  Gufic Biosciences jumps as board approves amalgamation of Gufic Lifesciences
 ( Hot Pursuit - 05-Apr-17   11:54 )
Other Stories
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
  Patel KNR Heavy Infrastructures reports standalone net loss of Rs 2.71 crore in the March 2024 quarter
  27-Jun-24   07:24
  Supreme Infrastructure India reports consolidated net loss of Rs 326.26 crore in the March 2024 quarter
  26-Jun-24   07:29
Back Top